News

“Targets for Tomorrow” Workshop at GRC in Italy July 2013

We invite you to join us for the “Targets for Tomorrow” satellite workshop hosted by the WGND Biology/Targets Subgroup on Monday, July 22, 2013 from 2 p.m. to 4:30 p.m. at the Renaissance Tuscany Il Ciocco Resort, Lucca (Barga), Italy. The workshop is held in conjunction with the Gordon Conference on TB Drug Development (July 21-26). The objectives of the meeting are to:

  • Allow key entities involved strategically in TB drug discovery to present their views of the needs, directions and targets for tomorrow to the research community
  • Discuss the puzzling finding of ‘promiscuous targets’
  • Set a priority list of what constitutes good targets and what does not to develop a universal “go/no go” checklist for targets
“Targets For Tomorrow” Satellite Workshop
AGENDA
Workshop Chair: Thomas Dick
2:00 p.m.-3:15pm: Needs & directions in TB drug discovery–Leader: Petros KarakousisSession Speakers:
  • Barbara Laughon (NIAID/NIH)
  • Ken Duncan (Bill & Melinda Gates Foundation)
  • Anna Upton (TB Alliance)
  • Alfonso Mendoza-Losana (GlaxoSmithKline)
  • Petros Karakousis (Johns Hopkins)
3:15-3:30pm: Break
3:30-4:30pm: ‘Promiscuous targets’–Leader: Tanya ParishDiscussion Topics:
  • What makes a good target—Speaker: Bavesh Kana
  • Results from current target ID efforts– Speaker: Dirk Schnappinger
  • Are promiscuous targets good or bad– Speaker: TBD
  • Best approaches to target-based screening—Speaker: Helena Boshoff

Light refreshments will be served.

If you plan on attending the satellite workshop, please RSVP by e-mailing wgnd@newtbdrugs.org.

More News
23 Aug 2022
Last week, the PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings...
4 May 2022
Earlier this week, the World Health Organization (WHO) released a rapid communication which detailed the upcoming changes to the treatment guidance for drug-resistant tuberculosis (DR-TB). These guidelines are used to inform national TB programmes globally on how to treat patients with these...
5 Apr 2022
On April 01, 2022, the Stop TB Partnership launched the second online consultation for the new Global Plan to End TB 2023-2030. Over the years, the Global Plans have been important tools for advocacy and resource mobilization, and served as a reference document for donors and stakeholders. In May...